Just over a month ago, at the BIO virtual conference, Pfizer Commercial Director John Young said the company was not thinking of a return on investment for its rapidly developing COVID-19 vaccine. Instead, he said, “finding medical solutions to this crisis” was a Pfizer priority. But now that the company …
Read More »
Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …
Read More »
Last week, FDA staff raised concerns about eye-related side effects that may come with GlaxoSmithKline’s BCMA cancer treatment. Despite questions about whether those problems, which include loss of vision, so severe patients stopped reading or driving, could be effectively identified and managed, the drug came out of an advisory committee …
Read More »
[ad_1] MUMBAI: Tata Motors, the flagship of the largest conglomerate in India Tata Group, has withdrawn plans to launch a Rs 1 billion non-convertible bond (ENT) offering, citing “higher cost expectations from participants due to tight money market conditions.” The decision comes two days after the company approved the issuance …
Read More »